MAP2K7 and neoplasm: We tested the durability of single agents, treating mice for 1 mo with MEK (1.5 mg/kg PD0325901) or SHP2 inhibitor (10 mg/kg), and then maintaining mice under off treatment for an additional 1 month, monitoring tumor volume.